- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03621176
Home-based Exercise in Chronic Kidney Disease (HBCKD-BCN)
Effects of Home-based Exercise in Advanced Chronic Kidney Disease and End-stage Renal Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Three groups of participants (advanced chronic disease not yet in substitutive treatment, end-stage renal disease patients in hemodialysis and end-stage renal disease patients in peritoneal dialysis) will enter the study. The intervention will consist of a home-based exercise program. They will be provided with a booklet and the researcher will explain personally each of the exercises to the participants. Progression will be encouraged so that the participants should find the sessions 'somewhat hard' according to the rate of perceived exertion. Reinforcement will be high during the first 3 months (weekly phone calls, visits to the nephrology department) and none during the last 3 months. Assessment will be undertaken at three-time points: baseline, after 3 months of high reinforcement and after 3 more months of no reinforcement at all.
Assessment will include strength, functional capacity, health-related quality of life, cognitive state and depressive symptoms.
The aim of the study is to assess the effectiveness of home-based exercise to improve strength, physical function, health-related quality of life, cognitive state and depressive symptoms in advanced chronic kidney disease and end-stage renal disease (hemodialysis and peritoneal dialysis). We also aim at describing all these variables in the three different groups of patients. Adherence and satisfaction with the exercise program will be recorded at the end of the study.
Additionally, interobserver reliability will be calculated, so as reliability intraobserver in different measurement conditions (dialysis vs non-dialysis days).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Barcelona
-
Terrassa, Barcelona, Spain, 08227
- Hospital de Terrassa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 3 months in hemodialysis treatment
- Clinically stable
Exclusion Criteria:
- Recent cardiac events (less than 3 months)
- Unable to exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Home-based exercise
Home-based intervention in the advanced chronic kidney disease group, hemodialysis or peritoneal dialysis group
|
A booklet with detailed information will be provided, and the exercises will be previously reviewed with every patient by the researcher.
Participants will be encouraged to perform at least 3 sessions per week and monitor their heart rate.
They will be instructed that the exercises should be perceived as 'somewhat hard' from a rate of perceived exertion.
Adaptations to increase the intensity of the exercises will be provided so that participants can progress in exercise intensity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline sit to stand 10 test at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Sit to stand to sit test 10, time to perform 10 repetitions
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Six-minute walking test at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Distance covered in 6 minutes
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline STS-60 at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Sit to stand to sit test 60, number of repetitions performed during 60 seconds
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline OLHR at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
One leg heel rise test, number of repetitions of heel rise to measure triceps strength
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline Handgrip strength (dynamometry) at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Handgrip strength measured through a dynamometer
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline SPPB at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Short physical performance battery, a combination of walking speed, STS-5 and balance
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline OLST at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
One-leg stand test, time to keep the balance in one leg
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline TUG at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Timed up and go test, time to stand up from a chair, walk 3m, turn around and sit back again
|
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
|
Change from baseline Albumin at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
|
Serum albumin in blood for dialysis patients
|
Baseline,12 weeks, 24 weeks
|
Change from baseline Health-related quality of life measured through the Euro quality of life questionnaire, 5 dimensions, at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
|
Euroquol 5D questionnaire, scale 0 (worst health) to 100 (best health).
5 Dimensions include mobility, personal care, activities of daily living, pain, and anxiety/depression
|
Baseline,12 weeks, 24 weeks
|
Change from baseline Beck depression inventory at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
|
Questionnaire to measure depressive symptoms.
Range from 0 (normal) to 63 (worst depression)
|
Baseline,12 weeks, 24 weeks
|
Change from baseline Human activity profile at 12 and 24 weeks Human activity profile
Time Frame: Baseline,12 weeks, 24 weeks
|
Questionnaire to measure physical activity.
Higher score represents higher activity.
Measures of average and maximal activity scores are reported.
Average activity scores bellow 53 are considered impaired; between 53 and 74 are considered moderately active and above 74 are considered active.
|
Baseline,12 weeks, 24 weeks
|
Change from baseline Physical Activity Scale for the elderly at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
|
Questionnaire to measure physical activity.
Higher scores represent higher activity.
|
Baseline,12 weeks, 24 weeks
|
Adherence
Time Frame: 12 weeks, 24 weeks
|
Sessions performed/offered x 100
|
12 weeks, 24 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Esteve Simo V, Junque Jimenez A, Moreno Guzman F, Carneiro Oliveira J, Fulquet Nicolas M, Pou Potau M, Saurina Sole A, Duarte Gallego V, Tapia Gonzalez I, Ramirez de Arellano M. Benefits of a low intensity exercise programme during haemodialysis sessions in elderly patients. Nefrologia. 2015;35(4):385-94. doi: 10.1016/j.nefro.2015.03.006. Epub 2015 Jul 21. English, Spanish.
- Segura-Orti E, Martinez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HBCKD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
A.C. AbrahamsCompletedEnd Stage Renal Disease | Chronic Kidney Disease | End Stage Kidney Disease | Chronic Kidney FailureNetherlands
-
Far Eastern Memorial HospitalActive, not recruitingMetabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Home-based exercise
-
University of OklahomaNational Institute on Aging (NIA); Milton S. Hershey Medical Center; Case Western...Not yet recruitingPeripheral Artery Disease | ClaudicationUnited States
-
University GhentTerminatedHypermobile Ehlers-Danlos Syndrome | Hypermobility Syndrome | Multidirectional Subluxation of ShoulderBelgium
-
University of WaterlooAlzheimer's AssociationCompletedDementia | Mild Cognitive ImpairmentCanada
-
Uskudar UniversityRecruitingAdolescent Idiopathic ScoliosisTurkey
-
Hacettepe UniversityCompletedKnee OsteoarthritisTurkey
-
University of FlorenceUnknownCardiovascular DiseaseItaly
-
Karolinska InstitutetMayo ClinicNot yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSweden
-
University of Sao PauloCompletedObesity | Bariatric SurgeryBrazil
-
Istanbul UniversityCompleted
-
Duke UniversityOncology Nursing Centers for ExcellenceTerminated